Signal Bay (OTCMKTS:SGBY) has completed its acquisition of Oregon analytical services, a full services cannabis testing facility.
As quoted in the press release:

Oregon Analytical Services has been providing full service analytical cannabis testing lab services in the greater Eugene area since 2014.  With a perpetual client base of over 500 cultivators, extractors, processors, edible manufacturers, and dispensaries, OAS has positioned itself as one of the dominant testing companies in Western Oregon.   Offering full compliance analytical testing services, including residual solvent and pesticide testing, OAS is centrally located to expand the service offering of EVIO Labs existing and proposed expansion labs within Oregon.

Signal Bay CEO William Waldrop said:

We are very proud to have achieved our goal of acquiring OAS in Eugene, Oregon, extending our cannabis lab footprint throughout Southern Oregon.  This acquisition complements our acquisition last year of Cannalytical Research in Bend, Oregon and our pending acquisition of Kenevir Research, another full-service cannabis test lab in Medford.  The acquisition Oregon puts EVIO Labs in a strong revenue position in the burgeoning Oregon cannabis marketplace. The next steps in the continued growth of EVIO Labs is to complete our acquisition of Kenevir Research, identify a prospective location in the Portland metropolitan area and open our previously announced lab testing facility in the Emerald Triangle of Northern California.

Click here for the full press release.


Cannabis - Will The Fortune 500 Join The Party?

Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less